Product Information
TESTOSTERONE 1% (25 MG/2.5 G) PK is a generic product labeled by Actavis Pharma, Inc., priced at $1.2039 per GM under NDC 00591321630. Its NADAC has been published 544 times since May 4, 2016.
FDA first approved this application on Jan 27, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00591321630
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONEApproval Type
Generic (ANDA)
FDA Application
ANDA076737FDA Approved
1/27/2006
TE Code
AB1
On Market Since
12/4/2015
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE 1% (25 MG/2.5 G) PK has been published 544 times since May 4, 2016, and over the history we have for it it has declined 67.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2039 per GM |
|---|---|
| All-time high | $4.5052 (Jul 13, 2016) |
| All-time low | $0.8358 (Jul 17, 2024) |
| 52-week high | $2.1430 |
| 52-week low | $1.1305 |
| Median price | $2.1173 |
| Average price | $2.1914 |
| Largest weekly change | +70.2% (Aug 21, 2024) |
| Weeks tracked | 544 |
| Tracking since | May 4, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE 1% (25 MG/2.5 G) PK?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE 1% (25 MG/2.5 G) PK, manufactured by Actavis Pharma, Inc., is $1.2039 per GM (NDC 00591321630), effective Sep 30, 2026.
How has the price of TESTOSTERONE 1% (25 MG/2.5 G) PK changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE 1% (25 MG/2.5 G) PK has declined 67.3%. It has been tracked across 544 weekly CMS publications since May 4, 2016.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE 1% (25 MG/2.5 G) PK?
Since May 4, 2016, the NADAC for TESTOSTERONE 1% (25 MG/2.5 G) PK has ranged from a low of $0.8358 (Jul 17, 2024) to a high of $4.5052 (Jul 13, 2016), with a median of $2.1173 per GM.
Are there cheaper alternatives to TESTOSTERONE 1% (25 MG/2.5 G) PK?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TESTOSTERONE 1% (50 MG/5 G) PK, is $0.4061 per GM — about 66% below TESTOSTERONE 1% (25 MG/2.5 G) PK.
Who manufactures TESTOSTERONE 1% (25 MG/2.5 G) PK?
TESTOSTERONE 1% (25 MG/2.5 G) PK (NDC 00591321630) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.